ARALEZ PHARMACEUTICALS INC's ticker is ARLZ and the CUSIP is 03852X100. A total of 1 filers reported holding ARALEZ PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | -100.0% | 0.00% | – |
| Q2 2018 | $0 | – | 425 | +41.7% | 0.00% | – |
| Q1 2018 | $0 | – | 300 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 300 | -79.1% | 0.00% | – |
| Q3 2017 | $3,000 | +50.0% | 1,436 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | -60.0% | 1,436 | -41.1% | 0.00% | – |
| Q1 2017 | $5,000 | -37.5% | 2,436 | +35.0% | 0.00% | – |
| Q4 2016 | $8,000 | +700.0% | 1,805 | +491.8% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 305 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | -50.0% | 305 | +1.7% | 0.00% | – |
| Q4 2015 | $2,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 289,664 | $434,000 | 0.43% |
| SALZHAUER MICHAEL | 220,153 | $330,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,644,583 | $2,467,000 | 0.08% |
| Brown Advisory Securities, LLC | 272,000 | $408,000 | 0.08% |
| Par Capital Management | 4,431,301 | $6,647,000 | 0.07% |
| ISTHMUS PARTNERS, LLC | 176,170 | $264,000 | 0.07% |
| FRANKLIN STREET ADVISORS INC /NC | 96,429 | $145,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 262,544 | $394,000 | 0.02% |
| Ballentine Partners, LLC | 100,000 | $150,000 | 0.01% |
| NWAM LLC | 20,000 | $30,000 | 0.01% |